Artificial intelligence (AI) software developer MaxQ AI's Accipio Ix and Accipio Ax intracranial hemorrhage (ICH) detection software will be available in Nuance Communications' AI Marketplace for Diagnostic Imaging.
MaxQ AI's Accipio ICH platform uses deep-learning technologies to analyze medical imaging data, helping physicians more quickly diagnose stroke, traumatic brain injury, and head trauma.
Accipio Ix software is designed for automatic identification and prioritization of noncontrast head CT images with suspected ICH. Accipio Ax provides automatic slice-level annotation of suspected ICH. Both software received clearance from the U.S. Food and Drug Administration and the CE Mark in Europe, according to MaxQ AI.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
